| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 |
| filingDate |
2018-09-06^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a82352dfcffc3685c9ba17a9bd14892
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82c38babae31e099dfec91a9eb010c7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4e19677667c99069b958e8686a1760c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c7588b59e5e8cdce67c1f8aa2784036 |
| publicationDate |
2019-03-07^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2019071413-A1 |
| titleOfInvention |
Cyclobutyl-Imidazolidinone Compounds |
| abstract |
The present invention provides a compound of Formula I n n n n n n n n n n n n wherein n Q is selected from the group consisting of —CH(CH 3 ) 2 and n n n n n n n n n n n n n n n n R is selected from the group consisting of n n n n n n n n n n n n n n orn a pharmaceutically acceptable salt thereof; compositions, methods to treat liver disease and NASH. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020531528-A |
| priorityDate |
2017-09-07^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |